Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer

Study ID
NCT02379039

Study type
Observational

Study phase

Study status
Completed

Trial Acronym

MORRIS

Trial Summary

The study's aim is to define imaging and molecular bio-markers for prediction of radiotherapy response of squamous cell carcinomas, in an early treatment phase.

More informations

Trial Starting Date

May 31,2015

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

118